A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Completed · Phase 2 · NCT05536804
Conditions: Overweight, Obesity, Chronic Kidney Disease, Type 2 Diabetes, T2D
At a glance
- Research payments reported, 2025
- $1.1M
- U.S. investigators named
- 11
- Sites paid
- 11
- Planned or actual enrollment
- 134
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- Tirzepatide (drug), Placebo (drug)
- Dates
- Started 2023-02-08; completion 2026-07-30
- Results posted
- Not yet
We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or without type 2 diabetes (T2D). The study will last about 56 weeks and include up to 12 visits.
From ClinicalTrials.gov, last updated 2026-09-11. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $1.1M in research payments for this study in 2025 (22 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Christopher G. Chow, MD Internal Medicine · Northridge, CA
- Melanie G. Cree, MD, PHD Pediatric Endocrinology · Aurora, CO
- Maria-gabriela Velez, MD Nephrology (Kidney) · Denver, CO
- Jonathan D. Condit, DO Family Medicine · Muncie, IN
- Andrew Daluga, M.D. Emergency Medicine · Greenfield, IN
- Allon N. Friedman, M.D. Internal Medicine · Indianapolis, IN
- Eric W. Hewitt, D.O. Family Medicine · Avon, IN
- Neil J. Fraser, MD Internal Medicine · Troy, MI
- Trent L. Wei, MD Interventional Cardiology · Greensboro, NC
- Laura Mayeda, MD Nephrology (Kidney) · Seattle, WA
- Katherine R. Tuttle, MD Nephrology (Kidney) · Spokane, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- American Health Network of in LLC $457,959
- Prov Sacred Hrt Med Ctr & Childs Hosp., WA $215,558
- Valley Clinical Trials Inc $155,758
- Indiana University $145,281
- Regents of the University of Colorado $47,314
- University of Washington Medical Ctr, WA $45,884
- Arcturus Healthcare PLC, Troy Internal $19,066
- Frenova LLC $4,171
- St Jude Heritage Healthcare $1,079
- Providence Medical Research Center - Spokane $154
- Cleveland Clinic, OH $53
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.